ANI Pharmaceuticals, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2008 | — | $13.8M | $11.8M |
| Dec 2009 | — | $15.8M | $29.9M |
| Jun 2010 | — | — | $46.4M |
| Sep 2010 | — | — | $35.5M |
| Dec 2010 | — | $19.1M | $38.2M |
| Mar 2011 | — | — | $51.3M |
| Jun 2011 | — | $11.5M | $37.1M |
| Sep 2011 | — | $44.1M | $69.6M |
| Dec 2011 | — | $-34.3M | $0 |
| Mar 2012 | — | $38.0M | $49.5M |
| Jun 2012 | — | $30.9M | $119.6K |
| Sep 2012 | — | $32.3M | $148.3K |
| Dec 2012 | — | $-42.7M | $11.0K |
| Mar 2013 | — | $26.0M | $41.0K |
| Jun 2013 | — | $35.5M | $12.6M |
| Sep 2013 | — | $36.7M | $10.9M |
| Dec 2013 | — | $41.0M | $11.1M |
| Mar 2014 | — | $92.1M | $51.4M |
| Jun 2014 | — | $91.6M | $53.0M |
| Sep 2014 | — | $99.5M | $35.1M |
| Dec 2014 | $106.5M | $139.8M | $169.0M |
| Mar 2015 | $112.2M | $144.7M | $165.6M |
| Jun 2015 | $113.7M | $149.5M | $166.7M |
| Sep 2015 | $115.2M | $155.9M | $150.9M |
| Dec 2015 | $113.4M | $160.1M | $154.7M |
| Mar 2016 | $115.2M | $160.2M | $77.7M |
| Jun 2016 | $117.0M | $163.8M | $15.0M |
| Sep 2016 | $118.8M | $168.8M | $16.2M |
| Dec 2016 | $0 | $169.6M | $27.4M |
| Mar 2017 | $122.5M | $172.2M | $10.8M |
| Jun 2017 | $124.4M | $176.5M | $8.4M |
| Sep 2017 | $126.3M | $182.8M | $18.0M |
| Dec 2017 | $69.9M | $174.8M | $31.1M |
| Mar 2018 | $68.6M | $179.6M | $52.0M |
| Jun 2018 | $67.3M | $185.1M | $55.0M |
| Sep 2018 | $66.0M | $192.5M | $44.1M |
| Dec 2018 | $67.3M | $197.3M | $43.0M |
| Mar 2019 | $66.5M | $199.7M | $38.2M |
| Jun 2019 | $65.7M | $207.7M | $40.6M |
| Sep 2019 | $64.9M | $213.1M | $59.7M |
| Dec 2019 | $175.8M | $212.8M | $62.3M |
| Mar 2020 | $188.1M | $201.2M | $20.4M |
| Jun 2020 | $177.9M | $191.3M | $27.7M |
| Sep 2020 | $175.2M | $195.1M | $17.9M |
| Dec 2020 | $172.4M | $195.7M | $7.9M |
| Mar 2021 | $169.0M | $203.7M | $25.1M |
| Jun 2021 | $189.5M | $191.9M | $24.3M |
| Sep 2021 | $186.1M | $191.4M | $15.3M |
| Dec 2021 | $286.5M | $333.9M | $100.3M |
| Mar 2022 | $286.3M | $321.2M | $76.9M |
| Jun 2022 | $286.1M | $312.1M | $63.4M |
| Sep 2022 | $285.9M | $311.8M | $56.3M |
| Dec 2022 | $285.7M | $313.7M | $48.2M |
| Mar 2023 | $285.5M | $314.6M | $67.8M |
| Jun 2023 | $285.2M | $409.6M | $161.7M |
| Sep 2023 | $285.0M | $429.9M | $193.1M |
| Dec 2023 | $284.8M | $432.7M | $221.1M |
| Mar 2024 | $284.6M | $452.0M | $228.6M |
| Jun 2024 | $284.4M | $455.8M | $240.1M |
| Sep 2024 | $312.9M | $405.9M | $145.0M |
| Dec 2024 | $309.1M | $403.7M | $144.9M |
| Mar 2025 | $305.3M | $418.6M | $149.8M |
| Jun 2025 | $301.5M | $436.8M | $217.8M |
| Sep 2025 | $297.7M | $505.8M | $262.6M |
| Dec 2025 | $291.8M | $540.7M | $285.6M |
| Mar 2026 | $286.0M | $562.3M | $311.2M |
| Jun 2026 | $280.2M | $597.2M | $360.2M |